Compare MTC & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTC | SRTS |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.8M | 79.3M |
| IPO Year | 2019 | 2016 |
| Metric | MTC | SRTS |
|---|---|---|
| Price | $4.30 | $4.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 41.6K | ★ 113.6K |
| Earning Date | 12-13-2024 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,675,833.00 | ★ $35,609,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 114.77 | N/A |
| 52 Week Low | $0.25 | $3.03 |
| 52 Week High | $3.89 | $7.00 |
| Indicator | MTC | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 73.15 | 52.64 |
| Support Level | $3.09 | $4.75 |
| Resistance Level | $3.61 | $5.15 |
| Average True Range (ATR) | 0.38 | 0.30 |
| MACD | 0.12 | -0.06 |
| Stochastic Oscillator | 87.37 | 34.72 |
MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.